NM_000088.4:c.2451+103T>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000088.4(COL1A1):​c.2451+103T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.378 in 1,243,044 control chromosomes in the GnomAD database, including 96,932 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 10477 hom., cov: 31)
Exomes 𝑓: 0.38 ( 86455 hom. )

Consequence

COL1A1
NM_000088.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.11

Publications

11 publications found
Variant links:
Genes affected
COL1A1 (HGNC:2197): (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A1 Gene-Disease associations (from GenCC):
  • Caffey disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-50190224-A-C is Benign according to our data. Variant chr17-50190224-A-C is described in ClinVar as Benign. ClinVar VariationId is 1268888.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.765 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A1NM_000088.4 linkc.2451+103T>G intron_variant Intron 35 of 50 ENST00000225964.10 NP_000079.2 P02452
COL1A1XM_011524341.2 linkc.2253+103T>G intron_variant Intron 32 of 47 XP_011522643.1
COL1A1XM_005257058.5 linkc.2451+103T>G intron_variant Intron 35 of 48 XP_005257115.2
COL1A1XM_005257059.5 linkc.1533+103T>G intron_variant Intron 22 of 37 XP_005257116.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A1ENST00000225964.10 linkc.2451+103T>G intron_variant Intron 35 of 50 1 NM_000088.4 ENSP00000225964.6 P02452
COL1A1ENST00000494334.1 linkn.*85T>G downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.354
AC:
53719
AN:
151536
Hom.:
10463
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.232
Gnomad AMI
AF:
0.169
Gnomad AMR
AF:
0.463
Gnomad ASJ
AF:
0.322
Gnomad EAS
AF:
0.787
Gnomad SAS
AF:
0.487
Gnomad FIN
AF:
0.413
Gnomad MID
AF:
0.232
Gnomad NFE
AF:
0.358
Gnomad OTH
AF:
0.362
GnomAD4 exome
AF:
0.381
AC:
416358
AN:
1091392
Hom.:
86455
Cov.:
15
AF XY:
0.385
AC XY:
214498
AN XY:
557764
show subpopulations
African (AFR)
AF:
0.219
AC:
5828
AN:
26594
American (AMR)
AF:
0.555
AC:
24320
AN:
43804
Ashkenazi Jewish (ASJ)
AF:
0.303
AC:
7063
AN:
23334
East Asian (EAS)
AF:
0.803
AC:
30464
AN:
37952
South Asian (SAS)
AF:
0.477
AC:
37422
AN:
78470
European-Finnish (FIN)
AF:
0.407
AC:
21400
AN:
52566
Middle Eastern (MID)
AF:
0.290
AC:
1463
AN:
5042
European-Non Finnish (NFE)
AF:
0.349
AC:
270559
AN:
775392
Other (OTH)
AF:
0.370
AC:
17839
AN:
48238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
14210
28420
42631
56841
71051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7360
14720
22080
29440
36800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.355
AC:
53774
AN:
151652
Hom.:
10477
Cov.:
31
AF XY:
0.366
AC XY:
27110
AN XY:
74118
show subpopulations
African (AFR)
AF:
0.232
AC:
9595
AN:
41282
American (AMR)
AF:
0.464
AC:
7082
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.322
AC:
1116
AN:
3470
East Asian (EAS)
AF:
0.785
AC:
4012
AN:
5108
South Asian (SAS)
AF:
0.488
AC:
2349
AN:
4814
European-Finnish (FIN)
AF:
0.413
AC:
4362
AN:
10558
Middle Eastern (MID)
AF:
0.236
AC:
69
AN:
292
European-Non Finnish (NFE)
AF:
0.358
AC:
24264
AN:
67842
Other (OTH)
AF:
0.366
AC:
771
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1692
3384
5075
6767
8459
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.357
Hom.:
1267
Bravo
AF:
0.354
Asia WGS
AF:
0.613
AC:
2128
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.8
DANN
Benign
0.63
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2075558; hg19: chr17-48267585; COSMIC: COSV56808761; COSMIC: COSV56808761; API